Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003136624 | SCV003819443 | uncertain significance | Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency | 2019-09-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246056 | SCV004948627 | uncertain significance | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.2641T>A (p.C881S) alteration is located in exon 18 (coding exon 16) of the SETD5 gene. This alteration results from a T to A substitution at nucleotide position 2641, causing the cysteine (C) at amino acid position 881 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |